American-Portuguese Biomedical Research Fund Inc (EIN 731188521) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

Rui M Costa

Phone

4053649134

Tax Period

2023-01-01 to 2023-12-31

American-Portuguese Biomedical Research Fund Inc, founded in 1990, is a micro nonprofit in the Medical Research sector that reported $12K in total revenue in fiscal year 2023. Revenue fell 71% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $6K, a strong 50% operating margin.

Mission

MEDICAL RESEARCH

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $12,226

Other Revenue $0

TOTAL REVENUE $12,226

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $0

Other Expenses $6,123

TOTAL EXPENSES $6,123

Year-over-Year Comparison

	2023	2022	Change
Revenue	$12,226	$42,188	-0.7%
Expenses	$6,123	$8,613	-0.3%
Net Income	$6,103	$33,575	-0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Rui M Costa	President	10.00	Officer Director	$0	$0	$0
David Lyden	VP	5.00	Officer	$0	$0	$0
Euretta Robinson	Interim Treasurer	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$12,226	$6,123	$420,601	$6,103
2022	$42,188	$8,613	$269,995	$33,575
2021	$29,384	$7,368	$344,869	$22,016
2020	$8,211	$14,417	$259,429	$-6,206
2019	$321	$24,627	$225,755	$-24,306
2018	$42,620	$23,487	$198,194	$19,133

American-Portuguese Biomedical Research Fund Inc